Gavin M. Spencer
Chief Executive Officer at NICOX SA
Network origin in Gavin M. Spencer first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
32
| Public Company | Pharmaceuticals: Major | 32 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Gavin M. Spencer via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Nicox Ophthalmics, Inc.
 Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Corporate Officer/Principal | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Uppsala | College/University | Undergraduate Degree Masters Business Admin Graduate Degree | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| NANEXA AB | Medical Specialties | Chairman Director/Board Member | |
Envisia Therapeutics, Inc.
 Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| INFANT BACTERIAL THERAPEUTICS AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin | |
| HARROW, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Royal Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
| VALERITAS INC | Medical Specialties | Director/Board Member Director/Board Member | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Astra Research Centre AB | Chairman Chief Tech/Sci/R&D Officer | ||
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TRANSGENE | Biotechnology | Director/Board Member Director/Board Member | |
| ACINO HOLDING AG | Pharmaceuticals: Major | Chairman | |
| University of St. Gallen | College/University | Masters Business Admin | |
| University of Massachusetts | College/University | Undergraduate Degree | |
Solvias AG
 Solvias AG BiotechnologyHealth Technology Solvias AG engages in contract research, development, and manufacturing. It offers analytical, small molecule, biopharmaceutical, solid state development, catalysis technology, custom synthesis and manufacturing, and biological analysis services. The firm serves the pharmaceutical, biotech, medical devices, cosmetics, agro chemical, chemical, eletronic materials, and life sciences industries. The company was founded in 1999 and is headquartered in Kaiseraugst, Switzerland. | Biotechnology | Chairman | |
EyeSense AG
 EyeSense AG Medical SpecialtiesHealth Technology EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland. | Medical Specialties | Chairman | |
Orasis Pharmaceuticals Ltd.
 Orasis Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Orasis Pharmaceuticals Ltd. operates as a clinical stage pharmaceutical company. It develops eye drops for the treatment of presbyopia as an alternative to reading glasses. The company was founded in 2015 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Ferring Pharmaceuticals Ltd.
 Ferring Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Novartis Ophthalmics AG | Chief Executive Officer | ||
Ferring International Center SA
 Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| Oculocare AG | Miscellaneous | Director/Board Member | |
Ferring Pharmaceuticals SA
 Ferring Pharmaceuticals SA BiotechnologyHealth Technology Ferring Pharmaceuticals SA develops and markets biopharmaceutical products. It provides products in the fields of reproductive health, urology, gastroenterology, endocrinology, and osteoarthritis. The company was founded by Frederik Paulsen Sr in 1950 and is headquartered in Saint-Prex, Switzerland. | Biotechnology | Director/Board Member | |
Ferring Holding SA
 Ferring Holding SA Pharmaceuticals: MajorHealth Technology Ferring Holding SA operates as a holding company with interests in pharmaceutical products. The company was founded in 2000 and is headquartered in Saint-Prex, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Ixodes AG
 Ixodes AG Pharmaceuticals: MajorHealth Technology Ixodes AG develops, produces and markets pharmaceutical products. It operates as a pharmaceutical company that improves patient lives through technologies for the prevention of Lyme disease. The firm's product Ixogel, is a solution to prevent Lyme disease via a topical application of an antibiotic after a tick bite. The company was founded in 2007 and is headquartered in Zumikon, Switzerland. | Pharmaceuticals: Major | Director of Finance/CFO | |
Sequana Medical AG
 Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Medical Specialties | Chairman | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
MURO Pharmaceuticals, Inc.
 MURO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of RAG-Stiftung, MURO Pharmaceuticals, Inc. manufactures pharmaceuticals, specifically allergy and asthma products. The company is based in Tewksbury, MA. MURO Pharmaceuticals was acquired by ASTA Medica AG on September 30, 1996 for $120.70 million. | Pharmaceuticals: Major | Sales & Marketing | |
Hybrigenics Services SASU
 Hybrigenics Services SASU Medical SpecialtiesHealth Technology Part of Hybrigenics SA, Hybrigenics Services SASU is a French company that specializes in exploring protein-protein interactions using their yeast two-hybrid platform. The company is based in Paris, France. With over 500 publications, they are experts in this field and can provide valuable insights for your project. Etienne Formstecher has been the CEO of the company since 2010. | Medical Specialties | Director/Board Member | |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Undergraduate Degree | |
Glaxo Wellcome Immobilière de Recherche SA
 Glaxo Wellcome Immobilière de Recherche SA Real Estate DevelopmentFinance Glaxo Wellcome Immobilière de Recherche SA provides real estate services. The company was founded in 1992 and is headquartered in Marly-le-Roi, France. | Real Estate Development | Corporate Officer/Principal | |
Orphan Europe SARL
 Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Orphan Europe SARL develops and distributes orphan drugs for the treatment of rare diseases. The firm's products include Normosang, Cystagon, Pedea, Carbaglu, Wilzin, Cystadane. The company was founded by William Gunnarsson in 1990 and is headquartered in Puteaux, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bausch & Lomb (Australia) Pty Ltd.
 Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
| United States | 17 |
| Switzerland | 13 |
| France | 10 |
| Sweden | 8 |
| United Kingdom | 3 |
Sectoral
| Health Technology | 37 |
| Consumer Services | 8 |
| Finance | 3 |
| Commercial Services | 2 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 221 |
| Corporate Officer/Principal | 86 |
| Chairman | 65 |
| Independent Dir/Board Member | 43 |
| Chief Executive Officer | 31 |
Most connected contacts
| Insiders | |
|---|---|
| Göran Albert Ando | 44 |
| Jean-Luc Bélingard | 40 |
| Adrienne Graves | 38 |
| Birgit Stattin Norinder | 29 |
| Vaughn M. Kailian | 27 |
| Frank Baldino | 23 |
| Damian Marron | 21 |
| Bengt Ingemar Samuelsson | 19 |
| Jean-François Labbé | 18 |
| Michele Garufi | 17 |
| Vicente J. Anido | 16 |
| Andreas Segerros | 16 |
| Luzi Andreas von Bidder | 16 |
| Jørgen Buus Lassen | 15 |
| Les Kaplan | 14 |
- Stock Market
- Insiders
- Gavin M. Spencer
- Company connections
